DK1083168T3 - Prostaglandinderivat - Google Patents

Prostaglandinderivat

Info

Publication number
DK1083168T3
DK1083168T3 DK99921247T DK99921247T DK1083168T3 DK 1083168 T3 DK1083168 T3 DK 1083168T3 DK 99921247 T DK99921247 T DK 99921247T DK 99921247 T DK99921247 T DK 99921247T DK 1083168 T3 DK1083168 T3 DK 1083168T3
Authority
DK
Denmark
Prior art keywords
group
cycloalkyl
vinylene
alkyl
alkyl group
Prior art date
Application number
DK99921247T
Other languages
English (en)
Inventor
Fumie Sato
Tohru Tanami
Kazuya Kameo
Kenji Yamada
Shigeru Okuyama
Naoya Ono
Original Assignee
Taisho Pharmaceutical Co Ltd
Fumie Sato
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd, Fumie Sato filed Critical Taisho Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DK1083168T3 publication Critical patent/DK1083168T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK99921247T 1998-05-25 1999-05-25 Prostaglandinderivat DK1083168T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP14262298 1998-05-25
PCT/JP1999/002721 WO1999061419A1 (fr) 1998-05-25 1999-05-25 Derive de prostaglandine

Publications (1)

Publication Number Publication Date
DK1083168T3 true DK1083168T3 (da) 2003-12-15

Family

ID=15319631

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99921247T DK1083168T3 (da) 1998-05-25 1999-05-25 Prostaglandinderivat

Country Status (14)

Country Link
US (2) US6329539B1 (da)
EP (2) EP1082961B1 (da)
JP (3) JP4354644B2 (da)
KR (2) KR100623941B1 (da)
CN (2) CN1144588C (da)
AT (2) ATE252555T1 (da)
AU (2) AU742118B2 (da)
CA (2) CA2334355C (da)
DE (2) DE69912277T2 (da)
DK (1) DK1083168T3 (da)
ES (2) ES2211083T3 (da)
HK (2) HK1037535A1 (da)
PT (1) PT1083168E (da)
WO (2) WO1999061419A1 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA01008955A (es) 1999-03-05 2002-04-24 Procter & Gamble Analogos de prostaglandinas selectivas de fp no saturadas de c16.
CA2389869A1 (en) 1999-11-24 2001-05-31 Taisho Pharmaceutical Co., Ltd. Preparation for nasal administration
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
MXPA04002006A (es) 2001-08-31 2004-06-07 Sucampo Ag Analogos de prostagladina como abridor del canal de cloruro.
WO2003048140A1 (fr) * 2001-12-03 2003-06-12 Japan Tobacco Inc. Compose azole et utilisation medicinale de celui-ci
US20040266880A1 (en) * 2002-02-22 2004-12-30 Fumie Sato Antipruritics
EP1553083B1 (en) * 2002-07-12 2009-08-26 Taisho Pharmaceutical Co., Ltd Prostaglandin derivatives
US7737182B2 (en) * 2002-08-09 2010-06-15 Taisho Pharmaceutical Co., Ltd. Pharmaceuticals for xerosis
EP1527781B1 (en) * 2002-08-09 2008-07-23 Taisho Pharmaceutical Co., Ltd Antipruritic agent
US7037522B2 (en) * 2002-09-27 2006-05-02 Western Holdings, L.L.C. Nocturnal muscle enhancing composition and method
AU2003301900A1 (en) * 2002-11-13 2004-06-03 Fumie Sato Antipruritic drug
US20060270740A1 (en) * 2003-02-20 2006-11-30 Taisho Pharmaceutical Co., Ltd. And Fumie Sato Prostaglandin derivatives
WO2004089918A1 (ja) * 2003-04-09 2004-10-21 Japan Tobacco Inc. 複素芳香５員環化合物及びその医薬用途
JP5382898B2 (ja) * 2004-02-06 2014-01-08 大正製薬株式会社 乾皮症治療剤

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07103096B2 (ja) 1987-01-28 1995-11-08 株式会社上野製薬応用研究所 プロスタグランジンｄ類およびそれを含む鎮静・睡眠剤
CA1322749C (en) 1987-01-28 1993-10-05 Ryuzo Ueno Prostaglandins of the d series, and tranquilizers and soporifics containing the same
DE4036140A1 (de) * 1990-11-09 1992-05-14 Schering Ag 9-halogen-11ss-hydroxy-prostaglandinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE69214953T2 (de) 1991-04-22 1997-02-20 Taiho Pharmaceutical Co Ltd Prostaglandin e1-analoge
JPH05117230A (ja) 1991-04-22 1993-05-14 Taisho Pharmaceut Co Ltd プロスタグランジン誘導体
EP0652211A1 (en) * 1992-07-24 1995-05-10 Taisho Pharmaceutical Co. Ltd Prostaglandin derivative
JP3408835B2 (ja) 1993-03-23 2003-05-19 大正製薬株式会社 Ｅ型プロスタグランジン類の製造方法
JP3579448B2 (ja) * 1993-12-29 2004-10-20 大正製薬株式会社 プロスタグランジン誘導体、その塩およびその使用
JP3506485B2 (ja) * 1994-04-19 2004-03-15 大正製薬株式会社 プロスタグランジン誘導体
US5599838A (en) * 1996-02-23 1997-02-04 Taisho Pharmaceutical Co., Ltd. Prostaglandin derivatives

Also Published As

Publication number Publication date
CA2333038A1 (en) 1999-12-02
US6329539B1 (en) 2001-12-11
KR20010043596A (ko) 2001-05-25
ATE252555T1 (de) 2003-11-15
HK1037610A1 (en) 2002-11-08
AU742232B2 (en) 2001-12-20
CN1144588C (zh) 2004-04-07
CA2333038C (en) 2008-12-02
DE69929594D1 (de) 2006-04-13
CA2334355A1 (en) 1999-12-02
KR20010043595A (ko) 2001-05-25
AU742118B2 (en) 2001-12-20
EP1082961A4 (en) 2001-07-11
WO1999061029A1 (fr) 1999-12-02
JP4354644B2 (ja) 2009-10-28
HK1037535A1 (en) 2002-11-08
CN1303292A (zh) 2001-07-11
CN1303370A (zh) 2001-07-11
KR100623941B1 (ko) 2006-09-13
ATE316378T1 (de) 2006-02-15
WO1999061419A1 (fr) 1999-12-02
DE69912277T2 (de) 2004-07-15
US6395786B1 (en) 2002-05-28
JP2000044477A (ja) 2000-02-15
EP1083168B1 (en) 2003-10-22
EP1082961A1 (en) 2001-03-14
ES2257860T3 (es) 2006-08-01
JP4409767B2 (ja) 2010-02-03
ES2211083T3 (es) 2004-07-01
EP1083168A4 (en) 2002-09-04
KR100570521B1 (ko) 2006-04-12
AU3851499A (en) 1999-12-13
CN1144783C (zh) 2004-04-07
DE69912277D1 (de) 2003-11-27
DE69929594T2 (de) 2006-12-07
EP1083168A1 (en) 2001-03-14
PT1083168E (pt) 2004-03-31
EP1082961B1 (en) 2006-01-25
CA2334355C (en) 2009-01-27
AU3851299A (en) 1999-12-13

Similar Documents

Publication Publication Date Title
ATE252555T1 (de) Prostaglandinderivate
ATE225770T1 (de) Difluoroprostaglandin-derivate und ihre anwendung
DE69828284D1 (de) Naphthyridinderivate oder salze davon
ES2166021T3 (es) Procedimiento para la preparacion de 4-aril-3-hidroximetilpiperidinas.
ES2046641T3 (es) Composicion antitumoral.
ATE455098T1 (de) Prostaglandin-derivate
CA2014521A1 (en) 2-Substituted N,N'-Ditrimethoxybenzoyl Piperazines, a Preparation Process of the Same and Therapeutic Compositions Containing Them
EA200500032A1 (ru) Производные ацилоксипирролидина и их применение в качестве лигандов v1b или v1b и v1a рецепторов
DE69829409D1 (de) Alkylaminoderivate
ATE275133T1 (de) 1,2-dihydro-2-oxochinolin-derivate
EA199900460A1 (ru) Производные бензолсульфоамида и лекарственные средства, содержащие упомянутые производные
HK1078072A1 (en) Prostaglandin derivatives
HUP9802938A2 (hu) 4-Cikloalkil-piperidin és 4-cikloalkil-alkil-piperidin-származékok, eljárás a vegyületek előállítására és a vegyületek alkalmazása a gyógyászatban
ATE86629T1 (de) 4-piperidincarboxamid-derivate.
DE69033459T2 (de) Prostaglandin-I-Analoga
DE3782229T2 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
DK0717990T3 (da) Præparat til behandling af lægemiddelafhængighed